Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Polymeric Nanovaccines for Immune Modulation"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (10 March 2022) | Viewed by 6411
Special Issue Editors
Interests: nanomaterials; nanomedicine; immunotherapy; nanovaccines
Special Issues, Collections and Topics in MDPI journals
Interests: stimulus-responsive nanoparticles; nanoparticle-based vaccine delivery; photo-immunotherapy
Special Issue Information
Vaccination is one of the most effective ways to cure human diseases. With the advancements in science and technology, nanovaccines comprising nanoparticles that are either used as adjuvants or carriers has emerged as one of the most effective treatment strategies for health promotion and disease prevention. Nanovaccines are reported to be highly efficient in inducing humoral and cell-mediated immune responses and demonstrate high antigen loading, enhanced immunogenicity, and controlled antigen presentation. Polymers from the natural or synthetic route are often used for developing nanovaccines which could be easily internalized by antigen-presenting cells and exert immune modulations owing to the unique physiochemical properties of nanoparticles.
We are calling for manuscripts detailing natural and synthetic polymeric nanovaccines, anticancer nanovaccine delivery systems, immune modulating polymeric nanoparticles, etc. We sincerely hope this Special Issue serves as a platform for the exchange of the latest developments in the field of polymeric nano vaccines.
Dr. Saji Uthaman
Prof. Dr. In-Kyu Park
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- polymeric nanovaccines
- anticancer nanovaccines
- infection and immunity
- humoral and cell-mediated immunity